DK
Dean J. Kereiakes
Highly rated in
38
conditions

Dr. Dean J. Kereiakes

The Christ Hospital Outpatient Center - Red Bank
Cincinnati, OH
Highly rated in
38
conditions
Specialties:Interventional Cardiology | Cardiology
Experience:45 Years
Clinical Trials:Currently Recruiting for 6 Trials
Accepts:New PatientsMedicare
Highly rated in
38
conditions
About|Expertise|Insurance|Location|Research
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Check Dr. Dean J. Kereiakes' experience treating your condition:
About Dr. Dean J. Kereiakes

Dean Kereiakes is an Interventional Cardiologist and a Cardiologist in Cincinnati, Ohio. Kereiakes has been practicing medicine for over 45 years and is highly rated in 38 conditions, according to our data. His top areas of expertise are Coronary Heart Disease, Atherosclerosis, Aortic Valve Stenosis, Stent Placement, and Percutaneous Coronary Intervention (PCI). He is licensed to treat patients in Ohio. Kereiakes is currently accepting new patients.

His clinical research consists of co-authoring 254 peer reviewed articles and participating in 26 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Dean J. Kereiakes it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Dean J. Kereiakes accepts the following insurance:

  •  Anthem
  •  CareSource
  •  Medical Health
  •  Buckeye Health
Call to see if your plan is accepted.
Locations
4440 Red Bank Rd, Cincinnati, OH 45227
Background & Education
Graduate Institution
University Of Cincinnati College Of Medicine, 1978
Specialties
Interventional Cardiology
Cardiology
Licenses
Internal Medicine in OH
Hospital Affiliations
St Elizabeth Covington
Mercy Health - Clermont Hospital
The Jewish Hospital - Mercy Health
Mercy Health - West Hospital
Mercy Health - Anderson Hospital
Mercy Health - Fairfield Hospital
Bethesda North Hospital
The Christ Hospital
Highland District Hospital
Margaret Mary Health
Atrium Medical Center
St Elizabeth Edgewood
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

26 Clinical Trials
ACURATE IDE: Transcatheter Replacement of Stenotic Aortic Valve Through Implantation of ACURATE in Subjects InDicatEd for TAVR
Enrollment Status: Recruiting
Publish Date: November 30, 2022
Intervention Type: Device
Study Phase: Not Applicable
Randomized Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study
Enrollment Status: Recruiting
Publish Date: November 08, 2022
Intervention Type: Device, Drug
Study Phase: Not Applicable
Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS)
Enrollment Status: Recruiting
Publish Date: October 17, 2022
Intervention Type: Device
Personalized Therapy Study - Heart Failure Risk Status (TriageHF) Post Approval Study
Enrollment Status: Recruiting
Publish Date: October 06, 2022
Intervention Type: Other
Personalized Therapy Study - Attain Stability Quad Post-Approval Study
Enrollment Status: Recruiting
Publish Date: August 10, 2022
Intervention Type: Device
Transfemoral Replacement of Aortic Valve With HLT MeriDIAN Valve Early Feasibility Trial
Enrollment Status: Recruiting
Publish Date: June 30, 2022
Intervention Type: Device
Study Phase: Not Applicable
A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With Established Cardiovascular Disease
Enrollment Status: Active, not recruiting
Publish Date: October 10, 2022
Intervention Type: Drug
Study Drug: TQJ230
Study Phase: Phase 3
A Study to Assess Safety and Effectiveness of the JenaValve Trilogy™ Heart Valve System in the Treatment of High Surgical Risk Patients With Symptomatic, Severe Aortic Regurgitation (AR)
Enrollment Status: Active, not recruiting
Publish Date: September 13, 2022
Intervention Type: Device
Study Phase: Not Applicable
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Enrollment Status: Completed
Publish Date: August 02, 2022
Intervention Type: Device
Study Phase: Not Applicable
The OPTIMIZE Trial to Assess the Procedural and Clinical Value of the Svelte IDS and RX Sirolimus Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions in a Randomized Study
Enrollment Status: Active, not recruiting
Publish Date: May 26, 2022
Intervention Type: Device
Study Phase: Not Applicable
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions.
Enrollment Status: Completed
Publish Date: May 19, 2022
Intervention Type: Device
Study Phase: Not Applicable
An Early Feasibility Study of the AccuCinch® Ventricular Restoration System in Patients With Prior Mitral Valve Intervention (PMVI) and Recurrent Mitral Regurgitation - The CorCinch-PMVI Study
Enrollment Status: Active, not recruiting
Publish Date: March 16, 2022
Intervention Type: Device
Study Phase: Not Applicable
An Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction (HFrEF) - The CorCinch-HFrEF Study
Enrollment Status: Active, not recruiting
Publish Date: March 16, 2022
Intervention Type: Device
Study Phase: Not Applicable
Early Feasibility Study of the AccuCinch® Ventricular Restoration System
Enrollment Status: Active, not recruiting
Publish Date: August 02, 2021
Intervention Type: Device
Study Phase: Not Applicable
A Prospective Global Randomized Trial Assessing the Safety and Efficacy of the BuMA Supreme™ Biodegradable Drug Coated Coronary Stent System for Coronary Revascularization in Patients With Stable Coronary Artery Disease or Non-ST Segment Elevation Acute Coronary Syndromes
Enrollment Status: Active, not recruiting
Publish Date: February 16, 2021
Intervention Type: Device
Study Phase: Not Applicable
CRYSTAL Study: A Multi-Center, Randomized, Controlled Trial to Demonstrate the Safety and Effectiveness of the MiStent II for the Revascularization of Coronary Arteries.
Enrollment Status: Not yet recruiting
Publish Date: September 04, 2020
Intervention Type: Device
Study Phase: Not Applicable
Convalescent CoVID-19 Plasma in the Treatment of High Risk CoVID-19 Disease
Enrollment Status: Unknown status
Publish Date: May 20, 2020
Intervention Type: Biological
Study Drug: Anti-COVID-19 Plasma
Study Phase: Early Phase 1
A Randomized Phase 1 Dose-Escalation Study in Healthy Volunteers and Subjects on Aspirin With Stable Coronary Artery Disease to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous RUC-4
Enrollment Status: Completed
Publish Date: February 19, 2020
Intervention Type: Drug
Study Phase: Phase 1
A Prospective, Randomized, Adaptive, Double-Blind, Sham-Controlled, Multicenter Study to Evaluate the ROX Coupler in Subjects With Hypertension
Enrollment Status: Terminated
Publish Date: May 13, 2019
Intervention Type: Other, Device
Study Phase: Not Applicable
Randomized, Double-Blind, Placebo-Controlled Phase I/II Study of the Safety and Efficacy of Intracoronary Delivery of Allogeneic Cardiosphere-Derived Cells in Patients With a Myocardial Infarction and Ischemic Left Ventricular Dysfunction
Enrollment Status: Terminated
Publish Date: April 09, 2019
Intervention Type: Biological, Drug
Study Phase: Phase 1/Phase 2
Percutaneous Ventricular Restoration in Chronic Heart Failure Due to Ischemic Heart Disease
Enrollment Status: Terminated
Publish Date: June 23, 2017
Intervention Type: Device
Study Phase: Phase 3
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Enrollment Status: Completed
Publish Date: June 09, 2017
Intervention Type: Drug
Study Phase: Phase 4
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Examine the Effect of Betahistine on Body Weight in Obese Subjects
Enrollment Status: Completed
Publish Date: April 21, 2015
Intervention Type: Behavioral, Drug
Study Phase: Phase 2
A Prospective Evaluation in a Non-Randomized Trial of the Safety and Efficacy of the Use of the TAXUS® ElementTM Paclitaxel-Eluting Coronary Stent System for the Treatment of De Novo Coronary Artery Lesions in Small Vessels
Enrollment Status: Completed
Publish Date: May 08, 2014
Intervention Type: Device
Study Phase: Phase 3
A Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of the TAXUS Element Paclitaxel-Eluting Coronary Stent System for the Treatment of De Novo Coronary Artery Lesions
Enrollment Status: Completed
Publish Date: May 08, 2014
Intervention Type: Device
Study Phase: Phase 3
Multi-Center, Single-Blind, Two-Arm, Randomized, Controlled, Non Inferiority Trial of the Conor CoStar Paclitaxel-Eluting Coronary Stent System vs the TAXUS DES in Patients With De Novo Lesions of the Native Coronary Arteries
Enrollment Status: Completed
Publish Date: August 04, 2011
Intervention Type: Device
Study Phase: Phase 3
View 20 Less Clinical Trials -
254 Total Publications
Differential Clinical Benefit With Contemporary Drug-Eluting Stents: Fact or Fancy?
Journal: JACC. Asia
Published: November 07, 2022
Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
TH
Timothy D. Henry
Dr. Timothy D. Henry
Interventional Cardiology | Cardiology
Highly rated in
27
conditions
Interventional Cardiology
Cardiology

Christ Hospital System

The Christ Hospital Medical Office Building

2123 Auburn Ave, 
Cincinnati, OH 
 6.2 mi

Timothy Henry is an Interventional Cardiologist and a Cardiologist in Cincinnati, Ohio. Henry has been practicing medicine for over 41 years and is highly rated in 27 conditions, according to our data. His top areas of expertise are Heart Attack, Angina, Cardiogenic Shock, Percutaneous Coronary Intervention (PCI), and Bone Marrow Aspiration. He is licensed to treat patients in Minnesota. Henry is currently accepting new patients.

RS
Dr. Rishi Sukhija
Interventional Cardiology | Cardiology
Highly rated in
18
conditions
Interventional Cardiology
Cardiology

UC Health

MidtownUC Health Physicians Office (Midtown)

3590 Lucille Dr, 
Cincinnati, OH 
 1.3 mi

Rishi Sukhija is an Interventional Cardiologist and a Cardiologist in Cincinnati, Ohio. Sukhija has been practicing medicine for over 27 years and is highly rated in 18 conditions, according to our data. His top areas of expertise are Coronary Heart Disease, Angina, Atherosclerosis, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR). He is licensed to treat patients in Ohio, Arkansas, and Indiana. Sukhija is currently accepting new patients.

IS
Dr. Ian J. Sarembock
Interventional Cardiology | Cardiology
Highly rated in
17
conditions
Interventional Cardiology
Cardiology

Christ Hospital System

The Christ Hospital Outpatient Center - Montgomery

11140 Montgomery Rd, 
Cincinnati, OH 
 8.6 mi

Ian Sarembock is an Interventional Cardiologist and a Cardiologist in Cincinnati, Ohio. Sarembock has been practicing medicine for over 48 years and is highly rated in 17 conditions, according to our data. His top areas of expertise are Mitral Valve Regurgitation, Aortic Valve Stenosis, Rheumatic Fever, Heart Valve Repair, and Aortic Valve Replacement. He is licensed to treat patients in Ohio. Sarembock is currently accepting new patients.